Automated Immunoassay Analyzers Market Size By Product (Immunofluorescence, Chemiluminescence, ELISA, Enzyme Linked Fluorescent System, Multiplexed Assay System, Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing), By End-use (Hospitals, Diagnostic Laboratories, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024
Published Date: June 2017 | 150 Pages | Report ID: GMI1727 Report Format: PDF
Automated Immunoassay Analyzers Market size was over USD 8 billion in 2016, with growth forecast of over 15% CAGR from 2017 to 2024.
U.S. Automated Immunoassay Analyzers Market Size, By Product, 2013-2024 (USD Billion)
The automated immunoassay analyzers market is set to flourish owing to the rising shift in trend towards lab automated coupled with increasing prevalence of infectious diseases. These products are gaining popularity due to incremental innovation to the existing products and extended clinical applications.
Recent trends of automation and integration has led to introduction of innovative products in the market, thus driving the automated immunoassay analyzers market. Various pharmaceutical and biotechnology companies are increasingly using them for drug discovery purposes. Industry players are competing on the basis immunoassay system features, throughput, and menu expansion to capture business share by gaining access to hospitals and laboratories.
Stringent regulatory requirements and high cost involved in transitioning from conventional to automated instruments should hinder the industry growth.
Automated Immunoassay Analyzers Market, By Product
Chemiluminescence immunoassay analyzers market held the largest revenue share in 2016, and expected to witness robust growth over the forecast years. The largest share is attributed to increasing use due to its high sensitivity, and accuracy of analyte detection resulting in accurate diagnosis. Automated enzyme-linked immunosorbent assay (ELISA) systems revenue is slated to exceed over USD 6 billion by 2024. It is expected to witness healthy growth owing to its extensive test menu at a relatively affordable cost.
Rising prevalence of infectious diseases and improved diagnosis quality has increased global industry demand. These systems have enabled speedy and accurate diagnosis of endocrine disorders, cardiac ailments and cancer. Its growing application in therapeutic drug monitoring should further boost the business growth.
Automated Immunoassay Analyzers Market, By Application
Infectious diseases held the largest automated immunoassay analyzers market share in 2016. Increasing incidence of infectious diseases in the developing countries fuelled business growth. For instance, pneumonia causes 1 in 5 deaths in children below five years of age globally, estimating to nearly 2 million deaths every year.
Cardiology should witness robust growth over the forecast years owing to the adoption of in cardiac marker testing for prevention of cardiovascular diseases. Rising incidence of cardiovascular disorders and increasing demand for minimally invasive treatment procedures should fuel industry growth.
Automated Immunoassay Analyzers Market, By End-Use
Hospitals accounted for the largest revenue share owing to consolidation trend among hospitals leading to high test volumes, and favorable health reforms to provide better hospital care. Moreover, increasing number of corporate hospital chains should also boost automated immunoassay analyzers market demand over the forecast years. Diagnostic laboratories should witness highest growth over the forecast years, owing to the rising number of diagnostic laboratories. The use of automated systems helps laboratories to use their skilled resources for more important activities such as analysis and test results review.
Growing preference for automated instruments in hospitals and laboratories has significantly improved the efficiency and quality of laboratory operations. These products can meet the increasing demand for quality diagnostic testing despite of staff shortage, a commonly faced problem by diagnostic laboratories.
Automated Immunoassay Analyzers Market, By Region
U.S. automated immunoassay analyzers market contributed more than 90% to the regional revenue share in 2016. Favorable government policies and rapid adoption of automated technology in diagnostic laboratories should contribute to business growth.
China automated immunoassay analyzers market should witness fastest growth over the forecast years due to improving healthcare infrastructure and huge patient pool available for diagnostic testing. Moreover, entry of leading manufacturers in this region should provide promising regional growth opportunities in the coming years.
Competitive Market Share
Some of the notable automated immunoassay analyzers market participants include Abbott Diagnostics, Biokit, Biomerieux, Luminex Corporation, Roche Diagnostics, and Siemens Healthcare. The major strategy adopted by industry players include launching of technologically advanced innovative products. Industry participants are also focusing on product portfolio expansion to suit the requirements of different laboratory settings in terms of test volumes, assay menu, automation level and budget to stay ahead of the competition.
Automated Immunoassay Analyzers Industry Background
Automated immunossay analyzers are widely used in clinical laboratories and hospitals to perform biochemical tests aimed at detection and estimation of concentration of substance in the samples. The automated immunoassay analyzers market faces challenges in terms of cost associated in shifting from conventional lab products to automated ones. Small scale laboratories do not quickly adopt to change in instrumentation due to factors such as system revaluation, staff training, standardization of protocol and long purchase processes. However, manufacturers are seeking to introduce budget friendly analyzer systems or offering replacement benefits to generate revenue. The increased focus on multiplex technologies that use peptide and protein arrays by the companies to introduce multi parametric assays systems should further help manufacturers to boost their revenue share.
What Information does this report contain?
Why Global Market Insights?Comprehensive Research
- All-inclusive coverage
- In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
- Penetrative insights & latest trends
- Offers holistic understanding of the market
- Unique methodology
- Iterative in nature to eliminate errors
- Detailed methodology, scope, assumptions and data sources available for reference
- Committed to making a positive difference for our clients
- Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
- Every purchase comes with an option to obtain additional information:
- up to 10% of the original cost
- 45-minute analyst tele-call to obtain further clarity on the market.
- Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
- Only PCI-DSS compliant payment methods used for highest level of client data security